EE200200057A - Kasvutegurit IL-5 pärssiv asauratsiilderivaat, selle saamine ja kasutamine ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon - Google Patents

Kasvutegurit IL-5 pärssiv asauratsiilderivaat, selle saamine ja kasutamine ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon

Info

Publication number: EE200200057A
Authority: EE; Estonia
Prior art keywords: pharmaceutical; formulation; preparation; growth factor; composition containing
Prior art date: 1999-08-06

Application number

EEP200200057A

Other languages

English (en)

Inventor

Jean Edgard Freyne Eddy

Fernand Armand Lacrampe Jean

Dirk Deroose Frederik

Michel Claude Fortin J�r�me

Coesemans Erwin

Original Assignee

Janssen Pharmaceutica N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-06

Filing date

2000-07-31

Publication date

2003-04-15

2000-07-31 Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.

2003-04-15 Publication of EE200200057A publication Critical patent/EE200200057A/et

Links

SSPYSWLZOPCOLO-UHFFFAOYSA-N 6-azauracil Chemical class O=C1C=NNC(=O)N1 SSPYSWLZOPCOLO-UHFFFAOYSA-N 0.000 title 1
108010002616 Interleukin-5 Proteins 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000003102 growth factor Substances 0.000 title 1
230000005764 inhibitory process Effects 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0461—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0463—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0468—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Optics & Photonics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Gynecology & Obstetrics (AREA)
Ophthalmology & Optometry (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Peptides Or Proteins (AREA)

EEP200200057A 1999-08-06 2000-07-31 Kasvutegurit IL-5 pärssiv asauratsiilderivaat, selle saamine ja kasutamine ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon EE200200057A (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP99870170		1999-08-06
EP99126035		1999-12-27
PCT/EP2000/007358 WO2001010866A1 (en)	1999-08-06	2000-07-31	Interleukin-5 inhibiting 6-azauracil derivatives

Publications (1)

Publication Number	Publication Date
EE200200057A true EE200200057A (et)	2003-04-15

Family

ID=26153219

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200057A EE200200057A (et)	1999-08-06	2000-07-31	Kasvutegurit IL-5 pärssiv asauratsiilderivaat, selle saamine ja kasutamine ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon

Country Status (30)

Country	Link
US (1)	US6911444B2 (et)
EP (1)	EP1206471B1 (et)
JP (1)	JP2003506451A (et)
KR (1)	KR100795484B1 (et)
CN (1)	CN1188410C (et)
AR (1)	AR025046A1 (et)
AT (1)	ATE318811T1 (et)
AU (1)	AU780047B2 (et)
BG (1)	BG106367A (et)
BR (1)	BR0013014A (et)
CA (1)	CA2380759A1 (et)
CO (1)	CO5050264A1 (et)
CZ (1)	CZ2002356A3 (et)
DE (1)	DE60026312T2 (et)
EA (1)	EA004740B1 (et)
EE (1)	EE200200057A (et)
ES (1)	ES2260031T3 (et)
HK (1)	HK1048634B (et)
HR (1)	HRP20020096A2 (et)
HU (1)	HUP0202692A3 (et)
IL (1)	IL147976A0 (et)
MX (1)	MXPA02001343A (et)
MY (1)	MY133512A (et)
NO (1)	NO322386B1 (et)
NZ (1)	NZ516506A (et)
PL (1)	PL353475A1 (et)
SK (1)	SK1642002A3 (et)
TR (1)	TR200200310T2 (et)
TW (1)	TWI271404B (et)
WO (1)	WO2001010866A1 (et)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8048917B2 (en)	2005-04-06	2011-11-01	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en)	2001-06-11	2007-06-19	Xenoport, Inc.	Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US7186855B2 (en)	2001-06-11	2007-03-06	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en)	2001-06-11	2004-11-16	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
EP1486490A1 (en)	2002-02-28	2004-12-15	Takeda Chemical Industries, Ltd.	Azole compounds
MXPA06013924A (es) *	2004-05-29	2007-07-18	7Tm Pharma As	Acidos tiazolaceticos sustituidos como ligandos crth2.
CA2735521A1 (en)	2008-09-04	2010-03-11	Boehringer Ingelheim International Gmbh	Indolizine inhibitors of leukotriene production
JP4743340B1 (ja)	2009-10-28	2011-08-10	セントラル硝子株式会社	保護膜形成用薬液
JP5690839B2 (ja)	2009-12-04	2015-03-25	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ロイコトリエン産生のベンゾイミダゾール阻害薬
PH12013500301A1 (en)	2010-08-16	2013-03-25	Boehringer Ingelheim Int	Oxadiazole inhibitors of leukotriene production
US8580829B2 (en)	2010-08-26	2013-11-12	Boehringer Ingelheim International Gmbh	Oxadiazole inhibitors of leukotriene production
EA201300389A1 (ru)	2010-09-23	2013-09-30	Бёрингер Ингельхайм Интернациональ Гмбх	Оксадиазольные ингибиторы продуцирования лейкотриена
WO2012040137A1 (en)	2010-09-23	2012-03-29	Boehringer Ingelheim International Gmbh	Oxadiazole inhibitors of leukotriene production
EP2632915B1 (en)	2010-10-29	2015-08-12	Boehringer Ingelheim International GmbH	Benzimidazole inhibitors of leukotriene production
US8772304B2 (en)	2010-11-01	2014-07-08	Boehringer Ingelheim International Gmbh	Benzimidazole inhibitors of leukotriene production
EP2651930B1 (en)	2010-12-16	2015-10-28	Boehringer Ingelheim International GmbH	Biarylamide inhibitors of leukotriene production
AR089853A1 (es)	2012-02-01	2014-09-24	Boehringer Ingelheim Int	Inhibidores de oxadiazol de la produccion de leucotrienos para terapia de combinacion, composicion farmaceutica, uso

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US42416A (en) *		1864-04-19		Improvement in harvesters
US10177A (en) *		1853-11-01		Improved pen and pencil case
FR2476087A1 (fr) *	1980-02-18	1981-08-21	Roussel Uclaf	Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
US4631278A (en)	1984-08-01	1986-12-23	Janssen Pharmaceutica N.V.	Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
CA1244024A (en)	1984-08-01	1988-11-01	Gustaaf M. Boeckx	.alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES
GB8602342D0 (en)	1986-01-30	1986-03-05	Janssen Pharmaceutica Nv	5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
BR9811678A (pt) *	1997-07-10	2000-09-19	Janssen Pharmaceutica Nv	Derivados de 6-azauracila de inibição de il-5
CA2294533A1 (en) *	1997-07-10	1999-01-21	Janssen Pharmaceutica N.V.	6-azauracil derivatives as il-5 inhibitors
EP0987265A1 (en)	1998-09-18	2000-03-22	Janssen Pharmaceutica N.V.	Interleukin-5 inhibiting 6-azauracil derivatives

2000
- 2000-07-31 EP EP00948015A patent/EP1206471B1/en not_active Expired - Lifetime
- 2000-07-31 EE EEP200200057A patent/EE200200057A/et unknown
- 2000-07-31 NZ NZ516506A patent/NZ516506A/xx unknown
- 2000-07-31 BR BR0013014-1A patent/BR0013014A/pt not_active Application Discontinuation
- 2000-07-31 MX MXPA02001343A patent/MXPA02001343A/es active IP Right Grant
- 2000-07-31 PL PL00353475A patent/PL353475A1/xx unknown
- 2000-07-31 AU AU61609/00A patent/AU780047B2/en not_active Ceased
- 2000-07-31 ES ES00948015T patent/ES2260031T3/es not_active Expired - Lifetime
- 2000-07-31 JP JP2001515675A patent/JP2003506451A/ja not_active Withdrawn
- 2000-07-31 HU HU0202692A patent/HUP0202692A3/hu unknown
- 2000-07-31 EA EA200200232A patent/EA004740B1/ru not_active IP Right Cessation
- 2000-07-31 TR TR2002/00310T patent/TR200200310T2/xx unknown
- 2000-07-31 HR HR20020096A patent/HRP20020096A2/hr not_active Application Discontinuation
- 2000-07-31 CZ CZ2002356A patent/CZ2002356A3/cs unknown
- 2000-07-31 HK HK03100718.8A patent/HK1048634B/zh not_active IP Right Cessation
- 2000-07-31 WO PCT/EP2000/007358 patent/WO2001010866A1/en not_active Ceased
- 2000-07-31 IL IL14797600A patent/IL147976A0/xx not_active IP Right Cessation
- 2000-07-31 AT AT00948015T patent/ATE318811T1/de not_active IP Right Cessation
- 2000-07-31 CN CNB008113394A patent/CN1188410C/zh not_active Expired - Fee Related
- 2000-07-31 DE DE60026312T patent/DE60026312T2/de not_active Expired - Fee Related
- 2000-07-31 CA CA002380759A patent/CA2380759A1/en not_active Abandoned
- 2000-07-31 SK SK164-2002A patent/SK1642002A3/sk not_active Application Discontinuation
- 2000-07-31 KR KR1020027000704A patent/KR100795484B1/ko not_active Expired - Fee Related
- 2000-08-03 MY MYPI20003534 patent/MY133512A/en unknown
- 2000-08-04 CO CO00058843A patent/CO5050264A1/es unknown
- 2000-08-04 TW TW089115824A patent/TWI271404B/zh not_active IP Right Cessation
- 2000-08-04 AR ARP000104044A patent/AR025046A1/es unknown
2002
- 2002-01-30 BG BG06367A patent/BG106367A/bg unknown
- 2002-02-05 NO NO20020565A patent/NO322386B1/no not_active IP Right Cessation
- 2002-02-14 US US10/075,876 patent/US6911444B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
MY133512A (en)	2007-11-30
EA004740B1 (ru)	2004-08-26
TWI271404B (en)	2007-01-21
BR0013014A (pt)	2002-04-16
HK1048634A1 (en)	2003-04-11
CN1368972A (zh)	2002-09-11
EA200200232A1 (ru)	2002-08-29
HRP20020096A2 (en)	2005-10-31
WO2001010866A1 (en)	2001-02-15
DE60026312D1 (de)	2006-04-27
CZ2002356A3 (cs)	2002-06-12
US6911444B2 (en)	2005-06-28
NZ516506A (en)	2004-02-27
CN1188410C (zh)	2005-02-09
NO20020565D0 (no)	2002-02-05
EP1206471B1 (en)	2006-03-01
AR025046A1 (es)	2002-11-06
TR200200310T2 (tr)	2002-08-21
HUP0202692A3 (en)	2003-01-28
HUP0202692A2 (hu)	2002-12-28
BG106367A (bg)	2002-09-30
CO5050264A1 (es)	2001-06-27
AU780047B2 (en)	2005-02-24
IL147976A0 (en)	2002-09-12
KR20020012317A (ko)	2002-02-15
NO322386B1 (no)	2006-09-25
HK1048634B (zh)	2005-09-30
PL353475A1 (en)	2003-11-17
MXPA02001343A (es)	2002-07-22
AU6160900A (en)	2001-03-05
NO20020565L (no)	2002-03-26
KR100795484B1 (ko)	2008-01-16
SK1642002A3 (en)	2003-03-04
JP2003506451A (ja)	2003-02-18
CA2380759A1 (en)	2001-02-15
ES2260031T3 (es)	2006-11-01
DE60026312T2 (de)	2006-12-21
US20030114453A1 (en)	2003-06-19
ATE318811T1 (de)	2006-03-15
EP1206471A1 (en)	2002-05-22

Publication	Publication Date	Title
EE200200057A (et)	2003-04-15	Kasvutegurit IL-5 pärssiv asauratsiilderivaat, selle saamine ja kasutamine ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
PL355433A1 (pl)	2004-04-19	Indolinony podstawione w pozycji 6, ich wytwarzanie oraz ich zastosowanie w kompozycjach farmaceutycznych
EE200000482A (et)	2002-02-15	Glütsiini ülekannet pärssiva ühendi kasutamine ravimi valmistamiseks, ühend, seda sisaldav kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks
EE200300171A (et)	2003-06-16	Kristalliline monohüdraat, meetodid selle valmistamiseks ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks
EE200200046A (et)	2003-04-15	8-fenüül-6,9-dihüdro-[1,2,4]triasolo[3,4-i]puriin-5-ooni derivaat, selle valmistamine ja raviotstarbeline kasutamine ning seda sisaldav farmatseutiline kompositsioon
EE200000483A (et)	2002-02-15	Glütsiini ülekannet pärssiva ühendi kasutamine ravimi valmistamiseks, ühend, seda sisaldav kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks
EE200300207A (et)	2003-08-15	Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
DK1263720T3 (da)	2009-09-28	Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme
PL396568A1 (pl)	2012-02-13	Krystaliczny bursztynian O-demetylo-wenlafaksyny, kompozycja farmaceutyczna, farmaceutyczna postać dawkowania, doustna postać dawkowania, zastosowanie oraz sposób wytwarzania krystalicznego bursztynianu O-demetylo-wenlafaksyny
AU2001237526A1 (en)	2001-11-22	Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
EE200100684A (et)	2003-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
AU2001290257A2 (en)	2003-05-01	Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en)	2002-06-27	Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
HUP0204242A3 (en)	2004-05-28	Novel 1,3-dihydro-2h-indol-2-one derivatives, their preparation and pharmaceutical compositions compositions containing them
DZ3311A1 (fr)	2001-09-07	Compositions pharmaceutiques contenant des derives de 3-amino-azetidine, les nouveaux derives et leur preparation
EE200300240A (et)	2003-08-15	Arüülitud furaan- ja tiofeenkarboksamiid, seda sisaldav ravimpreparaat ning ühendi kasutamine kaaliumikanali blokaatorina toimiva ravimi valmistamiseks
EE200100391A (et)	2002-10-15	Peptidüül-heterotsüklilised ketoonid, nende kasutamine ja farmatseutiline kompositsioon
IL150346A (en)	2010-12-30	Benzazole derivatives, their preparation and pharmaceutical compositions containing them
HUP0200155A3 (en)	2005-04-28	Thioamide derivatives, pharmaceutical compositions containing them and their use
HUP0103165A3 (en)	2003-03-28	Thiazoline acid derivatives, pharmaceutical compositions containig the same and their use
EE200000596A (et)	2002-06-17	Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod
EE04954B1 (et)	2008-02-15	Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm
IL145012A0 (en)	2002-06-30	Fluorine substituted triarylmethane derivatives and pharmaceutical compositions containing the same
HUP0204354A3 (en)	2006-01-30	Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same and their use
IL147282A0 (en)	2002-08-14	Novel aminothiazole derivatives, their preparation and pharmaceutical compositions containing them